Interpace Biosciences Completes Its Pharma Services Business Sale to Flagship Biosciences, Inc.


The Company announces the complete sale of the pharma services business which could impact the IDXG Stock. For more information regarding the Company's business, visit OTC Wiki. 

Interpace Biosciences Inc is a leading company that specializes in enabling personalized medicinal products. This Company has closed a definitive asset purchase agreement under the Flagship of Biosciences Inc. It has acquired the Company's pharma services business. 

The Company will also use the proceeds from the transaction for working capital requirements and investments to help drive the growth of its molecular diagnostics business. The president and CEO of the Company also announced that with the completion of the multiple transactions, we expect the Company to make progress.

Moreover, the company's driven ash flow will focus on molecular diagnostics that the Company is offering the best in class solutions and other diagnostic insights. Besides providing the IDXG Stock, the Company determines the presence of certain cancers in clinicians and their patients. 

About Interpace Biosciences:

Interpace Biosciences is an emerging leader in enabling personalized medicine. Besides offering the common stock under the name IDXG Stock, it offers specialized services along the therapeutic value chain, including early diagnosis and prognostic planning.

The multiple clinical services throughout the Interpace diagnostic provides the clinical use of the molecular diagnostic test, bioinformatics and pathology services for evaluation of the factor of risk and cancer.

It also leverages the latest technology in personalizing the patients and their management. For the diagnosis of thyroid cancer from the thyroid nodules, the Company is utilizing the next-generation sequencing assay. It also proprietary gene expression assay and much more. 

A financial statement analysis of IDXG Stock indicates that the short-term assets of this Company cover the short-term liabilities. On the other hand, all the long-term assets of this Company are also exceeding and hence covering the long-term liabilities. Moreover, the IDXG Stock holds the current price of 2.05 US dollars on September 21, 2022. 

Comments

Post a Comment

Popular posts from this blog

Trillium Gold Mines Inc- Overview

Image
TGLDF- Trillium Gold Mines Inc head office is based in Canada. The main activity of this company is to find new mineral assets on the earth. Currently, the company is working on gold exploration in the Red Lake. The company is involved in several projects, some of them are Newman Todd, Red Lake West, Shining Tree, copper lode west etc.  Trillium Gold Mines Inc-  TGLDF  is showing consistent growth in revenues for the last few years. The company started its operations on November 3, 2005, the company's head office is in Vancouver.  The current share price on 27 May 2022 is 0.31 (Canadian dollars).  On 8th March 2022, the company offered 1,25,0000  incentive stock to Its management ( include of directors and other employees). The offer also includes the option to buy a common share by its management.  On March 2, 2022. Trillium Gold Mines Inc announced the closing of c$7.5million brokered private placement. On April 26, 2022. Trillium Gold Mines
Read more

LGIQ Busienss Overview

Image
LGIQ Busienss Overview LGIQ started its operations on 4 November 2022 and the company head office is in NewYork, United States. The company is involved in digital marketing and lead generation solutions for its customers.  The company business has two-part: one is digital marketing and the other is consumer marketplace. The company provides e-commerce solutions to Europe, Asia and America. The company data management tools and funnels help you find the right business consumers. The company's target customers are small and medium-sized businesses.  Brent Suen is the Chief Executive Officer and the John MacNeil is the Chief Operating Officer. Approximately more than 37 employees are working in LOGIQ.  LGIQ Stock LGIQ Stock is currently (13 June 2022) selling at 0.39 US Dollars. For the last five years, the stock price has been showing a decrease in the price. The stock was trading at 88.54 US dollars on 2 January 2018, and after this, the stock price for company shares is consistent
Read more

H2O Innovation- Business Overview- HEOFF Stock

Image
  H20 Innovation Incorporation was founded in 2000 and the company's main office is in Quebec, Canada. Approximately more than 900 employees are working in the company. H2O Innovation Inc is providing innovative water treatment solutions. The company's water treatment technology is based on membrane filtration. The company operations are based on three categories: 1- Water technologies & Services 2- Speciality products 3- operations and maintenance services. It is offering the water treatment technology based on membrane filtration to the following businesses 1- Municipal or government sectors. 2- Industrial sector 3- The end-users of natural resources. 4- The services sector The company is also providing a digital solution for monitoring and optimization of the water treatment system Following are the products of the company: 1- FiberFlex for water treatment 2- FlexMBR for water treatment. 3- Speciality Chemicals. 4- Consumables products 5- Specialized products 6- Reverse
Read more